Improvement in viability was demonstrated by MTT assay and reduced cytotoxicity by G6PD assay in miR-196s expressing NPCs and NCs further suggested the beneficial effect of miR-196a in ameliorating HD cellular defects (Fig 4) [34]. This evidence concerns the gene G6PD and Huntington disease.